Publication | Closed Access

Influence of CD34+ marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemia

Cd34+ Marrow CellHematological MalignancyTransplantationMarrow TransplantationBone Marrow FailureMedicineChronic Myeloid LeukaemiaImmunologyHematologyAutoimmunityImmunotherapyOncologyCell TransplantationMyeloid Neoplasia